|
Unveiling an Overlooked Link-Promising Drug Efficacy in Lowering Withdrawal Rates in Cancer Trials-Reply.
|
JAMA Oncol
38236585
|
0 |
28.4 |
2024 |
|
A Phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.
|
Clin Cancer Res
38530846
|
0 |
11.5 |
2024 |
|
Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals.
|
Maturitas
38262089
|
0 |
4.9 |
2024 |
|
Baclofen for hiccups: a large mixed methods multisite study.
|
BMJ Support Palliat Care
36787986
|
0 |
2.7 |
2024 |
|
Dexamethasone and hiccups: a 2000-patient, telephone-based study.
|
BMJ Support Palliat Care
34903586
|
2 |
2.7 |
2024 |
|
Sexual and Gender Minority Invisibility in Cancer Studies: A Call for Effective Recruitment Methods to Address Cancer Disparities.
|
J Clin Oncol
37725780
|
0 |
45.3 |
2023 |
|
Rates of and Factors Associated With Patient Withdrawal of Consent in Cancer Clinical Trials.
|
JAMA Oncol
37347469
|
0 |
28.4 |
2023 |
|
Understanding Disparities: A Case Illustrative of the Struggles Facing Transgender and Gender Diverse Patients With Cancer.
|
J Natl Compr Canc Netw
36791758
|
0 |
13.4 |
2023 |
|
A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer.
|
Proc Natl Acad Sci U S A
37585460
|
1 |
11.1 |
2023 |
|
The Far-Reaching Ramifications of the I-DARE Curriculum Roadmap.
|
Mayo Clin Proc
38043988
|
0 |
8.9 |
2023 |
|
Pembrolizumab near the end of life in patients with metastatic pancreatic cancer: a multi-site consecutive series to examine survival and patient treatment burden.
|
Cancer Immunol Immunother
36872382
|
0 |
5.8 |
2023 |
|
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis.
|
Cancers (Basel)
37509234
|
0 |
5.2 |
2023 |
|
Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance Trials.
|
JCO Oncol Pract
37058684
|
0 |
4 |
2023 |
|
Vitamin and Mineral Supplementation, Weight Gain, and Poor Appetite in Patients With Cancer: Many Questions and Fewer Answers.
|
JCO Oncol Pract
38127854
|
0 |
4 |
2023 |
|
What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? a compilation of patient-reported outcomes.
|
PLoS One
36706101
|
0 |
3.7 |
2023 |
|
Gastrointestinal perforation after bevacizumab: a multi-site, single-institution study with a focus on survival.
|
World J Surg Oncol
37291587
|
0 |
3.2 |
2023 |
|
Social determinants of health: a need for better data capture in Asian American patients with hepatocellular cancer.
|
Support Care Cancer
37646853
|
0 |
3.1 |
2023 |
|
Measuring symptoms and toxicities: a 35-year experience.
|
Support Care Cancer
37498410
|
0 |
3.1 |
2023 |
|
Developing & integrating a mobile application tool into a survivorship clinic for esophageal cancer patients.
|
J Thorac Dis
37197528
|
1 |
2.5 |
2023 |
|
Loss of appetite in patients with cancer: an update on characterization, mechanisms, and palliative therapeutics.
|
Curr Opin Support Palliat Care
37499060
|
0 |
2.1 |
2023 |
|
Postpartum related intrahepatic cholangiocarcinoma with fusion and severe hyperbilirubinemia with response to FGFR inhibitor pemigatinib: case report and review.
|
J Gastrointest Oncol
38196530
|
0 |
2.1 |
2023 |
|
Cancer cachexia: learn from yesterday, live for today and hope for tomorrow.
|
Curr Opin Support Palliat Care
37499059
|
0 |
2.1 |
2023 |
|
Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer.
|
J Natl Cancer Inst Monogr
37139982
|
0 |
0.01 |
2023 |
|
Social Determinants of Health: A Need for Evidence-Based Guidelines on How to Capture Data on Underserved Patients.
|
Res Sq
36711509
|
0 |
0 |
2023 |
|
Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series.
|
Blood Cancer J
35078980
|
1 |
12.8 |
2022 |
|
Colorectal Cancer, Crohn-Like Lymphoid Reactions, Survival - And the Power of a Good Cup of Coffee!
|
Mayo Clin Proc
34996547
|
1 |
8.9 |
2022 |
|
A Cautionary Tale: Grouping Patients on Late Events.
|
Mayo Clin Proc
35135689
|
0 |
8.9 |
2022 |
|
Equity.
|
Cancer
35403209
|
0 |
6.2 |
2022 |
|
Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer.
|
Int J Gynecol Cancer
35680140
|
2 |
4.8 |
2022 |
|
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D).
|
Breast Cancer Res Treat
34625860
|
0 |
3.8 |
2022 |
|
Hiccups in patients with cancer: a multi-site, single-institution study of etiology, severity, complications, interventions, and outcomes.
|
BMC Cancer
35705907
|
0 |
3.8 |
2022 |
|
Reply to A. Rizzo et al.
|
JCO Precis Oncol
35294225
|
0 |
3.621 |
2022 |
|
A randomized, double-blinded feasibility trial of educational materials for hiccups in chemotherapy-treated patients with cancer.
|
Support Care Cancer
36515742
|
0 |
3.1 |
2022 |
|
Olaparib for ovarian cancer: a single-institution, multi-site qualitative study.
|
Support Care Cancer
35146567
|
1 |
3.1 |
2022 |
|
Understanding "Patient refuses" among 90+ year old patients with cancer or presumed cancer.
|
J Geriatr Oncol
35232696
|
1 |
3 |
2022 |
|
Evaluating and palliating hiccups.
|
BMJ Support Palliat Care
35443973
|
2 |
2.7 |
2022 |
|
Healthcare Providers' Experiences with Hiccups in Patients with Cancer: Report of a United States National Survey.
|
Am J Hosp Palliat Care
36172916
|
0 |
1.9 |
2022 |
|
"It's Like You Stuck a Pin in It:" African American/Black Patients Describe Cutaneous Toxicity From Epidermal Growth Factor Receptor Inhibitors.
|
Am J Hosp Palliat Care
35442101
|
0 |
1.9 |
2022 |
|
In Their Own Words, "Waiting Sucks:" A Qualitative Study of Medical Testing-Related Anxiety in Patients with Cancer.
|
Am J Hosp Palliat Care
35635257
|
1 |
1.9 |
2022 |
|
Cannabis in Cancer Survivors Who Report High Impact Chronic Pain: Findings from a 1500+ Patient Survey.
|
Am J Hosp Palliat Care
36469631
|
0 |
1.9 |
2022 |
|
Establishing the Groundwork for Clinical Trials With Hiccupops for Hiccup Palliation.
|
Am J Hosp Palliat Care
34985350
|
1 |
1.9 |
2022 |
|
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology.
|
Contemp Clin Trials Commun
35928285
|
1 |
1.524 |
2022 |
|
Olanzapine for cisplatin-induced hiccups: observations from a 338-patient study.
|
Ann Palliat Med
35542973
|
0 |
1.44 |
2022 |
|
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study.
|
J Patient Exp
35756962
|
0 |
0.01 |
2022 |
|
Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials.
|
J Natl Cancer Inst Monogr
36519818
|
3 |
0 |
2022 |
|
Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: a Report from Three Prospective Alliance Clinical Trials.
|
J Gastrointest Cancer
36251211
|
0 |
0 |
2022 |
|
Role of dietary carbohydrates on risk of lung cancer.
|
Lung Cancer
33756357
|
6 |
6.081 |
2021 |
|
Rare Adverse Events with Programmed Death-1 and Programmed Death-1 Ligand Inhibitors: Justification and Rationale for a Systematic Review.
|
Curr Oncol Rep
34037893
|
5 |
5.945 |
2021 |
|
Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review.
|
Curr Oncol Rep
34196836
|
0 |
5.945 |
2021 |
|
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial.
|
Oncologist
33604969
|
1 |
5.837 |
2021 |
|
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience.
|
JCO Precis Oncol
34778691
|
0 |
5.479 |
2021 |
|
Should Loss of Appetite Be Palliated in Patients with Advanced Cancer?
|
Curr Treat Options Oncol
33641020
|
2 |
5.08 |
2021 |
|
Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting.
|
Breast Cancer Res Treat
34117959
|
1 |
4.624 |
2021 |
|
Alpelisib-induced hyperglycemia in older patients with breast Cancer: Qualitative findings.
|
J Geriatr Oncol
33752998
|
2 |
3.929 |
2021 |
|
Metastatic or suspected metastatic cancer in patients 90 years of age or older: A single-institution, multi-site study.
|
J Geriatr Oncol
33811017
|
1 |
3.929 |
2021 |
|
Randomized, Double-Blind Trial on the Impact of Word Count in Cancer Clinical Trial Consent Forms.
|
JCO Oncol Pract
34125586
|
2 |
3.487 |
2021 |
|
Skeletal muscle mitochondrial dysfunction and muscle and whole body functional deficits in cancer patients with weight loss.
|
J Appl Physiol (1985)
34941442
|
8 |
3.3 |
2021 |
|
Does the cancer geriatric assessment (GA) introduce bias into clinical trials? Observations from 988 prospectively recruited patients.
|
J Geriatr Oncol
34920971
|
1 |
3 |
2021 |
|
Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736).
|
J Geriatr Oncol
34364834
|
2 |
3 |
2021 |
|
Frequency and Symptomatology of Hiccups in Patients With Cancer: Using an On-Line Medical Community to Better Understand the Patient Experience.
|
Am J Hosp Palliat Care
33792359
|
4 |
1.9 |
2021 |
|
Can older patients adopt and maintain a ketogenic diet? An observational study in support of clinical trials in older patients.
|
Medicine (Baltimore)
34964801
|
0 |
1.817 |
2021 |
|
Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical Trials.
|
J Cancer Educ
32385740
|
5 |
1.771 |
2021 |
|
The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.
|
J Natl Cancer Inst Monogr
34850897
|
6 |
0.01 |
2021 |
|
Advanced ovarian cancer patients identify opportunities for prehabilitation: A qualitative study.
|
Gynecol Oncol Rep
33718562
|
2 |
0 |
2021 |
|
Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603).
|
JCO Clin Cancer Inform
33852323
|
5 |
0 |
2021 |
|
How Did a Multi-Institutional Trial Show Feasibility of Electronic Data Capture in Older Patients With Cancer? Results From a Multi-Institutional Qualitative Study (Alliance A171902).
|
JCO Clin Cancer Inform
33877885
|
2 |
0 |
2021 |
|
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions.
|
CA Cancer J Clin
33002206
|
100 |
286.13 |
2020 |
|
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
|
Nat Commun
33057068
|
32 |
14.919 |
2020 |
|
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients.
|
J Cachexia Sarcopenia Muscle
32940014
|
11 |
12.91 |
2020 |
|
Adverse Event Burden Score-A Versatile Summary Measure for Cancer Clinical Trials.
|
Cancers (Basel)
33158080
|
11 |
6.639 |
2020 |
|
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).
|
Oncologist
32951293
|
4 |
5.837 |
2020 |
|
Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer.
|
Gynecol Oncol
32518016
|
4 |
5.482 |
2020 |
|
Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program.
|
Gynecol Oncol
33388156
|
0 |
5.304 |
2020 |
|
Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting.
|
J Biol Chem
33453990
|
9 |
5.157 |
2020 |
|
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
|
Breast Cancer Res Treat
32951084
|
1 |
4.624 |
2020 |
|
Leukocyte Telomere Length and Its Interaction with Germline Variation in Telomere-Related Genes in Relation to Pancreatic Adenocarcinoma Risk.
|
Cancer Epidemiol Biomarkers Prev
32312758
|
1 |
4.254 |
2020 |
|
Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma.
|
Cancer Epidemiol Biomarkers Prev
33187969
|
1 |
4.09 |
2020 |
|
Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer.
|
Pancreatology
33468394
|
5 |
3.977 |
2020 |
|
Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812).
|
J Geriatr Oncol
32950428
|
3 |
3.929 |
2020 |
|
Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer.
|
Support Care Cancer
32447502
|
2 |
3.359 |
2020 |
|
Patients' Perspectives and Advice on How to Discuss Sexual Orientation, Gender Identity, and Sexual Health in Oncology Clinics.
|
Am J Hosp Palliat Care
32212925
|
3 |
2.5 |
2020 |
|
Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers.
|
ESMO Open
33109627
|
16 |
2.409 |
2020 |
|
Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
|
Am J Clin Oncol
32349022
|
0 |
2.339 |
2020 |
|
Editorial: What about weight? Advocating for simplicity in cancer cachexia trials.
|
Curr Opin Support Palliat Care
33105242
|
0 |
2.302 |
2020 |
|
Editorial: Cancer cachexia - bridging the gap.
|
Curr Opin Support Palliat Care
33181606
|
0 |
2.302 |
2020 |
|
Hearing and Heeding the Voices of those With Advanced Illnesses.
|
J Palliat Care
32466734
|
0 |
2.25 |
2020 |
|
Conversations on Cancer Chemotherapy Cessation in Patients With Advanced Cancer: Qualitative Findings From a Multi-Institutional Study.
|
Am J Hosp Palliat Care
32495676
|
0 |
2.09 |
2020 |
|
Non-Squamous, Non-Basal Cell Cancers of the Skin: Exploring Associations Between Site of Disease and Depression.
|
Am J Hosp Palliat Care
33191782
|
0 |
2.09 |
2020 |
|
Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy.
|
Med Hypotheses
32763659
|
5 |
1.538 |
2020 |
|
The wasting-associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration.
|
JCSM Rapid Commun
32905522
|
7 |
0 |
2020 |
|
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
|
Oncologist
32663355
|
0 |
0 |
2020 |
|
Developing an Educational Intervention to Address Financial Hardship in Cancer Patients.
|
Mayo Clin Proc Innov Qual Outcomes
32793870
|
7 |
0 |
2020 |
|
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
|
J Clin Oncol
31339827
|
21 |
32.956 |
2019 |
|
Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss.
|
J Cachexia Sarcopenia Muscle
31429197
|
3 |
9.802 |
2019 |
|
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.
|
J Cachexia Sarcopenia Muscle
30920776
|
59 |
9.802 |
2019 |
|
Sarcopenia: A Time for Action. An SCWD Position Paper.
|
J Cachexia Sarcopenia Muscle
31523937
|
174 |
9.802 |
2019 |
|
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.
|
Leukemia
31073153
|
27 |
8.665 |
2019 |
|
Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review.
|
Cancers (Basel)
31769421
|
60 |
6.126 |
2019 |
|
Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).
|
Oncologist
30975921
|
2 |
5.025 |
2019 |
|
A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context.
|
Oncologist
31101701
|
7 |
5.025 |
2019 |
|
Numbers Have Life: A Commentary on "Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit".
|
Oncologist
30659080
|
0 |
5.025 |
2019 |
|
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance).
|
Ann Surg Oncol
31605327
|
2 |
4.061 |
2019 |
|
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
|
Pancreatology
31787526
|
8 |
3.996 |
2019 |
|
The Need to Prioritize and Re-prioritize Palliative Care Options: Smoking Cessation as a Case-in-Point.
|
Curr Treat Options Oncol
30903460
|
0 |
3.9 |
2019 |
|
Perspectives on the Medical, Quality of Life, and Economic Consequences of Hiccups.
|
Curr Oncol Rep
31858286
|
4 |
3.828 |
2019 |
|
A qualitative study of healthcare-related experiences of non-smoking women with lung cancer.
|
Support Care Cancer
30989430
|
0 |
3.603 |
2019 |
|
Breast cancer and aging: Standing on the shoulders of a giant.
|
J Geriatr Oncol
31201096
|
3 |
3.599 |
2019 |
|
Behavioral, psychological, and supportive care interventions in geriatric oncology: The Cancer and Aging Research Group infrastructure core.
|
J Geriatr Oncol
31383630
|
3 |
3.599 |
2019 |
|
How (and why) to ask the older cancer patient about sexual health and sexual minority status.
|
J Geriatr Oncol
31447290
|
2 |
3.599 |
2019 |
|
Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology.
|
J Geriatr Oncol
31201095
|
2 |
3.599 |
2019 |
|
Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study.
|
J Oncol Pract
31162996
|
16 |
3.551 |
2019 |
|
Impaired cardiac performance, protein synthesis, and mitochondrial function in tumor-bearing mice.
|
PLoS One
31851697
|
3 |
2.851 |
2019 |
|
Querying Patients With Cancer About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Health-Care Providers.
|
Am J Hosp Palliat Care
31601116
|
2 |
2.5 |
2019 |
|
Loratadine for Paclitaxel-Induced Myalgias and Arthralgias.
|
Am J Hosp Palliat Care
31315424
|
0 |
2.5 |
2019 |
|
Poly (ADP-Ribose) Polymerase Inhibition for Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Placebo-Controlled Trials.
|
J Palliat Med
30839241
|
5 |
2.238 |
2019 |
|
Teaching Health-Care Providers to Query Patients With Cancer About Sexual and Gender Minority (SGM) Status and Sexual Health.
|
Am J Hosp Palliat Care
30599758
|
3 |
1.638 |
2019 |
|
Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series.
|
Am J Hosp Palliat Care
30602311
|
1 |
1.638 |
2019 |
|
Editorial: Merging therapeutics and supportive care: synergy and yield.
|
Curr Opin Support Palliat Care
31644452
|
0 |
1.618 |
2019 |
|
The Role of Systemic Inflammation in Cancer-Associated Muscle Wasting and Rationale for Exercise as a Therapeutic Intervention.
|
JCSM Clin Rep
31134216
|
28 |
0 |
2019 |
|
Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials.
|
Mayo Clin Proc Innov Qual Outcomes
31193907
|
2 |
0 |
2019 |
|
ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.
|
Gastroenterology
30342032
|
45 |
17.373 |
2018 |
|
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711).
|
J Thorac Oncol
29608967
|
12 |
12.46 |
2018 |
|
Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups.
|
Cancer
30561776
|
17 |
5.772 |
2018 |
|
Looking Back, Looking Forward: The Ethical Framing of Complementary and Alternative Medicine in Oncology Over the Last 20 Years.
|
Oncologist
29523647
|
0 |
5.252 |
2018 |
|
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).
|
Oncologist
29674441
|
17 |
5.252 |
2018 |
|
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.
|
Oncologist
30409792
|
10 |
5.025 |
2018 |
|
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
|
J Am Geriatr Soc
30146695
|
30 |
4.18 |
2018 |
|
Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
|
Eur J Cardiothorac Surg
29293957
|
17 |
3.847 |
2018 |
|
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.
|
Breast Cancer Res Treat
29789969
|
3 |
3.471 |
2018 |
|
The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance).
|
J Geriatr Oncol
29602735
|
9 |
3.164 |
2018 |
|
Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622).
|
J Geriatr Oncol
29848457
|
4 |
3.164 |
2018 |
|
Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).
|
J Geriatr Oncol
29673807
|
3 |
3.164 |
2018 |
|
"Ultimately, mom has the call": Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy.
|
Health Expect
29655265
|
5 |
2.847 |
2018 |
|
Characterizing cancer cachexia in the geriatric oncology population.
|
J Geriatr Oncol
30196027
|
19 |
2.761 |
2018 |
|
Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?
|
Support Care Cancer
29797079
|
1 |
2.754 |
2018 |
|
What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study.
|
Support Care Cancer
29938306
|
4 |
2.635 |
2018 |
|
Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients.
|
J Palliat Med
29792535
|
5 |
2.477 |
2018 |
|
'The shoulders, clavicles, chest and thighs melt away': a compilation of reviews on cachexia.
|
Curr Opin Support Palliat Care
30300156
|
0 |
1.916 |
2018 |
|
A hunger for hunger: a review of palliative therapies for cancer-associated anorexia.
|
Ann Palliat Med
29860861
|
6 |
1.681 |
2018 |
|
Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer.
|
Am J Hosp Palliat Care
29724109
|
0 |
1.655 |
2018 |
|
Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer?
|
Am J Hosp Palliat Care
29983087
|
1 |
1.638 |
2018 |
|
Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.
|
J Oncol Pract
29558251
|
10 |
0 |
2018 |
|
Prevalence and Survival Impact of Pretreatment Cancer-Associated Weight Loss: A Tool for Guiding Early Palliative Care.
|
J Oncol Pract
29466074
|
27 |
0 |
2018 |
|
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.
|
Ann Oncol
28475678
|
10 |
13.926 |
2017 |
|
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.
|
Cancer
28493308
|
16 |
6.537 |
2017 |
|
Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort.
|
Cancer
28700816
|
3 |
6.537 |
2017 |
|
Epigenetics of cancer-associated muscle catabolism.
|
Epigenomics
28942676
|
10 |
4.979 |
2017 |
|
Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk.
|
Cancer Epidemiol Biomarkers Prev
28264873
|
6 |
4.554 |
2017 |
|
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers.
|
Gynecol Oncol
28461031
|
17 |
4.54 |
2017 |
|
Overcoming obstacles in the design of cancer anorexia/weight loss trials.
|
Crit Rev Oncol Hematol
28807233
|
13 |
4.495 |
2017 |
|
Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042).
|
Lung Cancer
28285698
|
3 |
4.486 |
2017 |
|
Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).
|
Breast Cancer Res Treat
28825227
|
5 |
3.605 |
2017 |
|
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).
|
Breast Cancer Res Treat
28283904
|
7 |
3.605 |
2017 |
|
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review.
|
Clin Colorectal Cancer
29576427
|
18 |
3.176 |
2017 |
|
The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).
|
J Geriatr Oncol
29233548
|
6 |
3.164 |
2017 |
|
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.
|
JCO Precis Oncol
30761385
|
4 |
2.951 |
2017 |
|
Cancer-associated weight loss: releasing its firm grip on negative clinical outcomes.
|
Curr Opin Support Palliat Care
28914643
|
1 |
2.073 |
2017 |
|
EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review.
|
Genes Cancer
28740577
|
23 |
0 |
2017 |
|
Cancer in Transgender Patients: One Case in 385,820 Is Indicative of a Paucity of Data.
|
J Oncol Pract
29257720
|
5 |
0 |
2017 |
|
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527.
|
J Clin Oncol
27992272
|
29 |
26.303 |
2016 |
|
Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.
|
J Clin Oncol
26755510
|
18 |
24.008 |
2016 |
|
A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer.
|
Ann Oncol
27287210
|
27 |
11.855 |
2016 |
|
Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors.
|
Oncologist
27449521
|
26 |
4.962 |
2016 |
|
Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer.
|
Gynecol Oncol
27235857
|
48 |
4.959 |
2016 |
|
Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers.
|
Sci Rep
27436510
|
24 |
4.259 |
2016 |
|
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
|
Breast Cancer Res Treat
27866278
|
5 |
3.605 |
2016 |
|
Menopausal hormone therapy in cancer survivors: A narrative review of the literature.
|
Maturitas
27621244
|
5 |
3.255 |
2016 |
|
Seizures in patients with primary brain tumors: what is their psychosocial impact?
|
J Neurooncol
26979915
|
9 |
2.98 |
2016 |
|
Gaps in nutritional research among older adults with cancer.
|
J Geriatr Oncol
27197919
|
19 |
2.852 |
2016 |
|
Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting.
|
J Geriatr Oncol
27197916
|
27 |
2.852 |
2016 |
|
Patient and family member perspectives on searching for cancer clinical trials: A qualitative interview study.
|
Patient Educ Couns
27578272
|
8 |
2.785 |
2016 |
|
The association between recent abuse and menopausal symptom bother: results from the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS).
|
Menopause
26783985
|
7 |
2.733 |
2016 |
|
Ovarian cancer patients' and their family members' perspectives on novel vaccine and virotherapy trials.
|
Clin Trials
27353282
|
1 |
2.715 |
2016 |
|
"Enjoy glass of wine before eating:" a randomized trial to test the orexigenic effects of this advice in advanced cancer patients.
|
Support Care Cancer
27039205
|
2 |
2.698 |
2016 |
|
A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome.
|
Support Care Cancer
27838777
|
4 |
2.676 |
2016 |
|
A Single-Institution Study of Demographics and Outcomes of Adult Patients With Multiple Cancers.
|
Cancer Control
27842336
|
0 |
2.576 |
2016 |
|
Communication predictors and consequences of Complementary and Alternative Medicine (CAM) discussions in oncology visits.
|
Patient Educ Couns
27296081
|
18 |
2.429 |
2016 |
|
Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.
|
Oncology
26780780
|
5 |
2.262 |
2016 |
|
Self-reported verbal abuse in 1300+ older women within a private, tertiary women's health clinic.
|
Arch Gerontol Geriatr
27255349
|
2 |
2.086 |
2016 |
|
Do Ovarian Cancer Patients with a Family History of Cancer (Suspected BRCA1 or BRCA2 Mutation) Suffer Greater Chemotherapy Toxicity?
|
Cancer Invest
27791391
|
2 |
2.007 |
2016 |
|
Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma.
|
Am J Hosp Palliat Care
27151973
|
6 |
1.533 |
2016 |
|
Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss.
|
Oncol Lett
27895795
|
22 |
1.39 |
2016 |
|
I'm Still Me: Inspiration and Instruction from Individuals with Brain Cancer.
|
J Health Care Chaplain
27398684
|
2 |
0 |
2016 |
|
Request for regulatory guidance for cancer cachexia intervention trials.
|
J Cachexia Sarcopenia Muscle
26675232
|
57 |
9.697 |
2015 |
|
Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
|
J Thorac Oncol
26200277
|
73 |
6.595 |
2015 |
|
Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.
|
Oncotarget
26437224
|
12 |
5.008 |
2015 |
|
Risk-adjusted outcomes in elderly endometrial cancer patients: implications of the contrasting impact of age on progression-free and cause-specific survival.
|
Gynecol Oncol
25895615
|
6 |
4.959 |
2015 |
|
The impact of a spiritual legacy intervention in patients with brain cancers and other neurologic illnesses and their support persons.
|
Psychooncology
26643586
|
4 |
3.455 |
2015 |
|
Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival.
|
BMC Cancer
26471496
|
3 |
3.288 |
2015 |
|
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301).
|
Psychooncology
25994447
|
10 |
3.095 |
2015 |
|
Ureteral obstruction in cancer patients: a qualitative study.
|
Psychooncology
26101949
|
1 |
3.095 |
2015 |
|
Should Vital Signs Be Routinely Obtained Prior to Intravenous Chemotherapy? Results From a 2-Center Study.
|
Cancer Control
26678980
|
0 |
2.821 |
2015 |
|
Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers.
|
Support Care Cancer
25015057
|
25 |
2.698 |
2015 |
|
Response.
|
Support Care Cancer
25975674
|
0 |
2.698 |
2015 |
|
The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment.
|
Nutr Cancer
25664980
|
25 |
2.447 |
2015 |
|
Radiation-Refractory Brain Metastases in Patients with Non-Small Cell Lung Cancer.
|
J Palliat Med
26218580
|
0 |
2.23 |
2015 |
|
The Clinical and Research Infrastructure of a Childhood Cancer Survivor Program.
|
J Cancer Educ
25099236
|
5 |
1.329 |
2015 |
|
The feasibility and educational value of Hear My Voice, a chaplain-led spiritual life review process for patients with brain cancers and progressive neurologic conditions.
|
J Cancer Educ
24952300
|
3 |
1.329 |
2015 |
|
Disease-free ovarian cancer patients report severe pain and fatigue over time: prospective quality of life assessment in a consecutive series.
|
Eur J Gynaecol Oncol
26050353
|
2 |
0.692 |
2015 |
|
A Chaplain-led Spiritual Life Review Pilot Study for Patients with Brain Cancers and Other Degenerative Neurologic Diseases.
|
Rambam Maimonides Med J
25973267
|
1 |
0 |
2015 |
|
Health professionals' attitudes toward the detection and management of cancer-related anorexia-cachexia syndrome, and a proposal for standardized assessment.
|
J Community Support Oncol
26029935
|
9 |
0 |
2015 |
|
Non–small-cell lung cancer in elderly patients: a discussion of treatment options.
|
J Clin Oncol
25071101
|
19 |
24.008 |
2014 |
|
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force.
|
Ann Oncol
24569913
|
102 |
11.855 |
2014 |
|
Patients' rationale for declining participation in a cancer-associated weight loss study.
|
J Cachexia Sarcopenia Muscle
24622952
|
4 |
9.697 |
2014 |
|
A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer.
|
Int J Cancer
25273947
|
60 |
6.513 |
2014 |
|
Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.
|
J Gerontol A Biol Sci Med Sci
24770389
|
11 |
5.957 |
2014 |
|
Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy.
|
Gynecol Oncol
24434057
|
15 |
4.959 |
2014 |
|
Incidence and outcomes of chemotherapy and radiation in morbidly obese patients with locally advanced lung and esophageal cancers: a single-institution experience.
|
Cancer Control
24357743
|
1 |
3.896 |
2014 |
|
Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival.
|
Support Care Cancer
25339620
|
10 |
2.698 |
2014 |
|
Causes and palliation of transfusion-associated vaginal bleeding in patients with metastatic cancer.
|
Int J Gynecol Cancer
24270998
|
0 |
2.369 |
2014 |
|
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients.
|
Oncology
25502607
|
17 |
2.262 |
2014 |
|
Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignancies.
|
Oncology
24902997
|
5 |
2.262 |
2014 |
|
Discovering and targeting the epigenetic pathways to treat muscle loss: working toward a paradigm shift in cancer therapeutics.
|
Curr Opin Support Palliat Care
25319277
|
0 |
2.045 |
2014 |
|
Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer.
|
Am J Hosp Palliat Care
25552305
|
8 |
1.283 |
2014 |
|
Pemetrexed for ovarian cancer: a systematic review of the published literature and a consecutive series of patients treated in a nonclinical trial setting.
|
Case Rep Oncol
25232324
|
3 |
0.815 |
2014 |
|
Nutritional status, CT body composition measures and survival in ovarian cancer.
|
Gynecol Oncol
23523419
|
17 |
4.959 |
2013 |
|
Listening in on difficult conversations: an observational, multi-center investigation of real-time conversations in medical oncology.
|
BMC Cancer
24093624
|
11 |
3.288 |
2013 |
|
Self-perceptions of age among 292 chemotherapy-treated cancer patients: Exploring associations with symptoms and survival.
|
J Geriatr Oncol
23795225
|
3 |
2.852 |
2013 |
|
Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer.
|
Anticancer Drugs
23962904
|
26 |
2.32 |
2013 |
|
Ostomies in rectal cancer patients: what is their psychosocial impact?
|
Eur J Cancer Care (Engl)
24118361
|
6 |
2.104 |
2013 |
|
Anti-inflammatory therapy: exploring exercise, serum-derived bovine immunoglobulin/protein isolates, and ruxolitinib for the cancer-associated weight loss syndrome.
|
Curr Opin Support Palliat Care
24189891
|
4 |
2.045 |
2013 |
|
Preoperative testing before noncardiac surgery: guidelines and recommendations.
|
Am Fam Physician
23547574
|
23 |
1.822 |
2013 |
|
Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature.
|
J Cancer Educ
23872949
|
7 |
1.329 |
2013 |
|
Hospice in end-of-life patients with cancer: does it lead to changes in nonhospice health care utilization after stopping cancer treatment?
|
Am J Hosp Palliat Care
23666617
|
3 |
1.283 |
2013 |
|
Are 5-7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed? Observations from a Case Series.
|
Case Rep Oncol
23898278
|
2 |
0.635 |
2013 |
|
Asphyxiation with a fentanyl patch.
|
Case Rep Oncol
23741217
|
0 |
0.635 |
2013 |
|
Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma.
|
J Thorac Oncol
22134072
|
56 |
6.595 |
2012 |
|
Quality of life and symptom burden among long-term lung cancer survivors.
|
J Thorac Oncol
22134070
|
67 |
6.595 |
2012 |
|
Effect of cigarette smoking on quality of life in small cell lung cancer patients.
|
Eur J Cancer
22244802
|
30 |
6.029 |
2012 |
|
Cancer diagnoses in Iraqi refugees.
|
Acta Oncol
22404173
|
8 |
3.156 |
2012 |
|
Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.
|
J Geriatr Oncol
23166580
|
1 |
2.852 |
2012 |
|
Overall survival and self-reported fatigue in patients with esophageal cancer.
|
Support Care Cancer
22842921
|
10 |
2.698 |
2012 |
|
Nasal septal perforation from bevacizumab: a discussion of outcomes, management, and pharmacovigilance.
|
Curr Oncol Rep
22544558
|
1 |
2.608 |
2012 |
|
A pilot study of long-acting octreotide for symptomatic malignant ascites.
|
Oncology
22572824
|
7 |
2.262 |
2012 |
|
The positive impact of a facilitated peer mentoring program on academic skills of women faculty.
|
BMC Med Educ
22439908
|
38 |
1.572 |
2012 |
|
Who is counseled to lose weight? Survey results and anthropometric data from 3,149 lower socioeconomic women.
|
J Community Health
21744160
|
7 |
1.388 |
2012 |
|
Adjuvant chemotherapy and targeted therapy in elderly non-small-cell lung cancer patients.
|
Aging health
23185210
|
1 |
0 |
2012 |
|
Definition and classification of cancer cachexia: an international consensus.
|
Lancet Oncol
21296615
|
1701 |
33.9 |
2011 |
|
Adjuvant chemotherapy in colon cancer: ageism or appropriate care?
|
J Clin Oncol
21768475
|
3 |
24.008 |
2011 |
|
Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies.
|
Annu Rev Med
20731602
|
121 |
13.609 |
2011 |
|
Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice.
|
Carcinogenesis
21551128
|
1 |
5.105 |
2011 |
|
Parenteral nutrition in patients with advanced cancer: merging perspectives from the patient and healthcare provider.
|
Semin Oncol
21600375
|
0 |
3.5 |
2011 |
|
Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer.
|
J Pain Symptom Manage
21398090
|
20 |
2.905 |
2011 |
|
The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors.
|
J Pain Symptom Manage
21398089
|
26 |
2.905 |
2011 |
|
An overview of the European Society of Medical Oncology (ESMO) Symposium on Cancer and Nutrition 2009: from cancer prevention to nutrition support to alleviating suffering in patients with advanced cancer.
|
Support Care Cancer
21881911
|
1 |
2.698 |
2011 |
|
Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).
|
Support Care Cancer
21922203
|
8 |
2.698 |
2011 |
|
A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab.
|
Med Oncol
21399996
|
11 |
2.634 |
2011 |
|
How important is palliative care?
|
Curr Oncol Rep
21479994
|
1 |
2.608 |
2011 |
|
The purported effects of alcohol on appetite and weight in lung cancer patients.
|
Nutr Cancer
21999412
|
2 |
2.447 |
2011 |
|
Is Spanish language a barrier to domestic violence assessment?
|
J Womens Health (Larchmt)
21631373
|
1 |
2.322 |
2011 |
|
End-of-life hospital costs in cancer patients: do advance directives or routes of hospital admission make a difference?
|
Oncology
21677456
|
8 |
2.262 |
2011 |
|
Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients.
|
Oncology
21894050
|
4 |
2.262 |
2011 |
|
Epidermal growth factor receptor (EGFR) inhibitor-induced rash: a consecutive patient series that illustrates the need for rigorous palliative trials.
|
J Palliat Med
21226620
|
4 |
2.23 |
2011 |
|
Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting?
|
Eur J Cancer Care (Engl)
19708947
|
0 |
2.104 |
2011 |
|
Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians.
|
J Am Board Fam Med
21383221
|
3 |
2.053 |
2011 |
|
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222.
|
Cancer Invest
21345074
|
1 |
1.847 |
2011 |
|
Former military officers from the Republic of Vietnam now living in the united states (US): exploring their perceptions of the US healthcare system.
|
J Community Health
21461762
|
1 |
1.388 |
2011 |
|
Pain and other symptom severity in women with fibromyalgia and a previous hysterectomy.
|
J Pain Res
22003306
|
5 |
1.36 |
2011 |
|
Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment.
|
J Cancer Educ
20857352
|
1 |
1.329 |
2011 |
|
Practical strategies to circumvent and/or surmount six barriers in health disparities research: observations from a pilot project among Vietnamese Americans.
|
J Cancer Educ
21461954
|
0 |
1.329 |
2011 |
|
Spinal intradural extraosseous Ewing's sarcoma.
|
Rare Tumors
21464880
|
7 |
0.22 |
2011 |
|
A systematic compilation of reports published on opioid-related problems.
|
J Opioid Manag
21434583
|
4 |
0 |
2011 |
|
A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422).
|
Ann Oncol
20570832
|
13 |
11.855 |
2010 |
|
Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors.
|
J Thorac Oncol
20975604
|
9 |
6.595 |
2010 |
|
Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4).
|
Oncologist
20798191
|
14 |
5.826 |
2010 |
|
Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients.
|
Acta Oncol
21108568
|
6 |
3.156 |
2010 |
|
A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors.
|
Psychooncology
20865737
|
3 |
3.095 |
2010 |
|
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials.
|
Int J Oncol
20126980
|
14 |
3.079 |
2010 |
|
Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study.
|
Dig Dis Sci
20094784
|
11 |
2.875 |
2010 |
|
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).
|
Support Care Cancer
20820817
|
20 |
2.698 |
2010 |
|
STEPP for the EGFR inhibitor-induced rash--definitely a step in the right direction.
|
Curr Oncol Rep
20437117
|
1 |
2.608 |
2010 |
|
Oral cancer chemotherapy: the critical interplay between patient education and patient safety.
|
Curr Oncol Rep
20437116
|
16 |
2.608 |
2010 |
|
What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey.
|
J Palliat Med
20636153
|
10 |
2.23 |
2010 |
|
E-mail and photographs: a case report of a patient-initiated diagnostic tool in the era of electronic communication.
|
J Palliat Med
20178438
|
3 |
2.23 |
2010 |
|
Parenteral nutrition in patients with cancer: recent guidelines and a need for further study.
|
Curr Opin Support Palliat Care
20802337
|
1 |
2.045 |
2010 |
|
Cancer patients and their companion animals: results from a 309-patient survey on pet-related concerns and anxieties during chemotherapy.
|
J Cancer Educ
20180089
|
2 |
1.329 |
2010 |
|
Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy.
|
J Oncol Pract
21037876
|
1 |
0 |
2010 |
|
Rash from newer cancer agents: why do we still not have effective therapy for palliation and/or prevention?
|
J Support Oncol
20822033
|
1 |
0 |
2010 |
|
Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs).
|
Oncologist
19276294
|
40 |
5.826 |
2009 |
|
Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.
|
Lung Cancer
19497635
|
33 |
4.294 |
2009 |
|
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).
|
Lung Cancer
19665818
|
75 |
4.294 |
2009 |
|
In search of rigorous data on how to palliate the EGFR inhibitor-induced rash.
|
Oncology (Williston Park)
19323303
|
0 |
3.963 |
2009 |
|
Osseous metastases: drugs that enhance bone integrity and prevent adverse skeletal events.
|
Expert Opin Pharmacother
19351222
|
1 |
3.894 |
2009 |
|
Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222.
|
Cancer Manag Res
21188124
|
2 |
3.851 |
2009 |
|
Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.
|
Ann Thorac Surg
19161745
|
94 |
3.7 |
2009 |
|
Cancer chemotherapy: with or without food?
|
Support Care Cancer
19484482
|
1 |
2.698 |
2009 |
|
The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer.
|
Support Care Cancer
20012999
|
11 |
2.698 |
2009 |
|
Bisphosphonates: preventing skeletal morbidity and maybe doing more.
|
Curr Oncol Rep
19508828
|
0 |
2.608 |
2009 |
|
Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147.
|
Oncology
19622902
|
22 |
2.262 |
2009 |
|
Morbidity and mortality in patients with cancer who become nonambulatory after spinal cord compression: a case series on end-of-life care.
|
J Palliat Med
19254194
|
4 |
2.23 |
2009 |
|
If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology trainees.
|
J Cancer Educ
19526407
|
1 |
1.329 |
2009 |
|
Palliating hiccups in cancer patients: moving beyond recommendations from Leonard the lion.
|
J Support Oncol
19731577
|
6 |
0 |
2009 |
|
Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer.
|
J Gastrointest Cancer
19728180
|
5 |
0 |
2009 |
|
An update on advance directives in the medical record: findings from 1186 consecutive patients with unresectable exocrine pancreas cancer.
|
J Gastrointest Cancer
19127451
|
10 |
0 |
2009 |
|
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).
|
J Clin Oncol
18640932
|
100 |
24.008 |
2008 |
|
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer.
|
Mol Ther
18388964
|
22 |
6.688 |
2008 |
|
Should we recommend surgery to patients with limited small cell carcinoma of the esophagus?
|
J Thorac Oncol
19057258
|
7 |
6.595 |
2008 |
|
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).
|
J Thorac Oncol
18449005
|
13 |
6.595 |
2008 |
|
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).
|
Cancer
18543329
|
49 |
6.072 |
2008 |
|
Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy.
|
Oncologist
18988655
|
16 |
5.826 |
2008 |
|
Cachexia: a new definition.
|
Clin Nutr
18718696
|
776 |
4.548 |
2008 |
|
Motivational readiness for physical activity and quality of life in long-term lung cancer survivors.
|
Lung Cancer
18243406
|
32 |
4.294 |
2008 |
|
Side effects and pharmaceutical company bias: adverse event reporting in cancer supportive and palliative care trials.
|
Expert Opin Investig Drugs
19012496
|
0 |
4.03 |
2008 |
|
Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report.
|
Psychooncology
18050362
|
6 |
3.095 |
2008 |
|
Rash from EGFR inhibitors: opportunities and challenges for palliation.
|
Curr Oncol Rep
18778556
|
14 |
2.608 |
2008 |
|
Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions.
|
J Nutr Educ Behav
18457782
|
8 |
2.491 |
2008 |
|
Weight loss in patients with advanced cancer: effects, causes, and potential management.
|
Curr Opin Support Palliat Care
18685394
|
6 |
2.045 |
2008 |
|
A survey of patient advocates within the National Cancer Institute's Prostate Cancer SPORE Program: who are they? what motivates them? what might they tell us?
|
J Cancer Educ
19058069
|
1 |
1.329 |
2008 |
|
Do gender-based disparities in authorship also exist in cancer palliative care? A 15-year survey of the cancer palliative care literature.
|
J Cancer Educ
18709592
|
0 |
1.329 |
2008 |
|
Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy.
|
Ther Clin Risk Manag
19337442
|
6 |
0.578 |
2008 |
|
Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E.
|
Clin Med Oncol
21892283
|
0 |
0 |
2008 |
|
Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis.
|
J Support Oncol
18551861
|
13 |
0 |
2008 |
|
Wine for appetite loss: "how do you know?".
|
J Clin Oncol
17401021
|
1 |
24.008 |
2007 |
|
Current management strategies for ovarian cancer.
|
Mayo Clin Proc
17550756
|
89 |
6.686 |
2007 |
|
Wanted--and Needed--more studies in geriatric lung cancer patients.
|
J Thorac Oncol
17410022
|
0 |
6.595 |
2007 |
|
A critical look at the role of chemotherapy in older patients with non-small cell lung cancer.
|
J Thorac Oncol
17410017
|
1 |
6.595 |
2007 |
|
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
|
Cancer
17674351
|
47 |
6.072 |
2007 |
|
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer.
|
Cancer
17542000
|
18 |
6.072 |
2007 |
|
Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort.
|
Oncologist
18165623
|
35 |
5.826 |
2007 |
|
Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
|
Int J Radiat Oncol Biol Phys
17394940
|
29 |
5.133 |
2007 |
|
Pharmacological options for advanced cancer patients with loss of appetite and weight.
|
Expert Opin Pharmacother
17516872
|
4 |
3.894 |
2007 |
|
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044).
|
Am J Clin Oncol
17921712
|
8 |
3.259 |
2007 |
|
Non-traumatic vertebral fractures in patients with locally advanced esophageal cancer: a previously unreported, unrecognized problem.
|
Dis Esophagus
17439592
|
3 |
2.571 |
2007 |
|
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.
|
Urology
17320666
|
22 |
2.309 |
2007 |
|
Who should receive parenteral nutrition or pharmacologic therapy for loss of appetite and weight in the setting of incurable cancer?
|
Curr Opin Support Palliat Care
18685375
|
0 |
2.045 |
2007 |
|
Shopping for nutrition-based complementary and alternative medicine on the Internet: how much money might cancer patients be spending online?
|
J Cancer Educ
17760524
|
2 |
1.329 |
2007 |
|
Symptom control trials: a 20-year experience.
|
J Support Oncol
17410810
|
9 |
0 |
2007 |
|
Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach.
|
J Support Oncol
17136864
|
6 |
0 |
2007 |
|
Sunshine and rash: testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash.
|
Support Cancer Ther
18632517
|
4 |
0 |
2007 |
|
Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trial.
|
Support Cancer Ther
18632476
|
7 |
0 |
2007 |
|
Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.
|
J Support Oncol
17265786
|
7 |
0 |
2007 |
|
Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group.
|
Ann Oncol
16497828
|
17 |
11.855 |
2006 |
|
Causes and outcomes of spontaneous pneumothoraces in solid tumor cancer patients: an update for the medical oncologist.
|
J Thorac Oncol
17409880
|
5 |
6.595 |
2006 |
|
Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients.
|
Clin Nutr
16867306
|
6 |
4.548 |
2006 |
|
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies.
|
Cancer Chemother Pharmacol
16763792
|
14 |
2.737 |
2006 |
|
New agents, new rashes: an update on skin complications from cancer chemotherapy.
|
Curr Oncol Rep
17254526
|
2 |
2.608 |
2006 |
|
The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer.
|
Dis Esophagus
16866854
|
2 |
2.571 |
2006 |
|
Curing patients with locally advanced esophageal cancer: an update on multimodality therapy.
|
Dis Esophagus
17069587
|
4 |
2.571 |
2006 |
|
Antiemetic properties of megestrol acetate.
|
J Palliat Med
16629544
|
0 |
2.23 |
2006 |
|
Why do oncologists prescribe--or not prescribe--conventional chemotherapy to geriatric patients with metastatic non-small cell lung cancer?
|
J Support Oncol
16892691
|
2 |
0 |
2006 |
|
Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across Minnesota.
|
Minn Med
17094362
|
0 |
0 |
2006 |
|
Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
|
J Support Oncol
15357517
|
8 |
0 |
2006 |
|
Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.
|
J Soc Integr Oncol
17022922
|
0 |
0 |
2006 |
|
Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.
|
J Clin Oncol
16361618
|
25 |
24.008 |
2005 |
|
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.
|
Ann Oncol
16303863
|
17 |
11.855 |
2005 |
|
Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience.
|
Cancer
15641035
|
16 |
6.072 |
2005 |
|
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.
|
Cancer
15852407
|
10 |
6.072 |
2005 |
|
Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome?
|
Crit Rev Oncol Hematol
15927842
|
1 |
4.971 |
2005 |
|
Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution.
|
Lung Cancer
16022915
|
0 |
4.294 |
2005 |
|
Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort.
|
Lung Cancer
15949593
|
11 |
4.294 |
2005 |
|
Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group.
|
Support Care Cancer
15759136
|
11 |
2.698 |
2005 |
|
The cancer anorexia/weight loss syndrome: therapeutic challenges.
|
Curr Oncol Rep
15946586
|
8 |
2.608 |
2005 |
|
Omega-3 fatty acid supplements for cancer-associated weight loss.
|
Nutr Clin Pract
16207679
|
1 |
2.468 |
2005 |
|
Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: results from the Mayo Clinic lung cancer cohort.
|
Nutr Cancer
15749624
|
4 |
2.447 |
2005 |
|
Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group.
|
Support Cancer Ther
18632438
|
3 |
0 |
2005 |
|
Total parenteral nutrition in cancer patients: why and when?
|
Nutr Clin Care
16013227
|
0 |
0 |
2005 |
|
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
|
J Clin Oncol
15197210
|
52 |
24.008 |
2004 |
|
The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer.
|
Curr Med Chem
15078173
|
1 |
4.63 |
2004 |
|
Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.
|
Lung Cancer
15165094
|
7 |
4.294 |
2004 |
|
Environmental tobacco smoke exposure in women with lung cancer.
|
Lung Cancer
14739032
|
11 |
4.294 |
2004 |
|
Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs.
|
Support Care Cancer
15480814
|
7 |
2.698 |
2004 |
|
A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients.
|
Support Care Cancer
15372221
|
3 |
2.698 |
2004 |
|
Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial.
|
Support Care Cancer
15278681
|
6 |
2.698 |
2004 |
|
Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group.
|
Dis Esophagus
15569365
|
0 |
2.571 |
2004 |
|
Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group.
|
Int Semin Surg Oncol
15533252
|
2 |
0 |
2004 |
|
Tumor Necrosis Factor-alpha as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome.
|
Support Cancer Ther
18628148
|
2 |
0 |
2004 |
|
Glutamine does not prevent paclitaxel-associated myalgias and arthralgias.
|
J Support Oncol
15334869
|
17 |
0 |
2004 |
|
Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management.
|
J Support Oncol
15328816
|
2 |
0 |
2004 |
|
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.
|
J Clin Oncol
12874270
|
54 |
24.008 |
2003 |
|
On appetite and its loss.
|
J Clin Oncol
12743203
|
3 |
24.008 |
2003 |
|
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.
|
Cancer
12627508
|
67 |
6.072 |
2003 |
|
Why should we care about the cancer anorexia/weight loss syndrome?
|
Oncology (Williston Park)
12632868
|
0 |
3.963 |
2003 |
|
A phase II study of topical ceramides for cutaneous breast cancer.
|
Breast Cancer Res Treat
12889603
|
7 |
3.626 |
2003 |
|
Aggressive multimodality therapy for patients with locally advanced esophageal cancer: is there a role for amifostine?
|
Semin Oncol
14727244
|
0 |
3.355 |
2003 |
|
Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study.
|
Am J Clin Oncol
14528068
|
5 |
3.259 |
2003 |
|
Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients.
|
Support Care Cancer
14505160
|
7 |
2.698 |
2003 |
|
Myelodysplastic syndromes.
|
Am J Clin Pathol
15298141
|
0 |
2.4 |
2003 |
|
Adenosine triphosphate: does it help cancer patients "get bigger and stronger"?
|
J Clin Oncol
11786561
|
1 |
24.008 |
2002 |
|
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
|
J Clin Oncol
11786587
|
107 |
24.008 |
2002 |
|
Esophageal cancer and the esophagus: challenges and potential strategies for selective cytoprotection of the tumor-bearing organ during cancer treatment.
|
Semin Radiat Oncol
11917287
|
3 |
5.356 |
2002 |
|
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation.
|
Support Care Cancer
11777191
|
8 |
2.698 |
2002 |
|
A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia.
|
Int J Gastrointest Cancer
12794247
|
9 |
0 |
2002 |
|
Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation.
|
Cancer
11505408
|
8 |
6.072 |
2001 |
|
An update: cancer-associated anorexia as a treatment target.
|
Curr Opin Clin Nutr Metab Care
11517349
|
2 |
4.023 |
2001 |
|
Current management of cancer-associated anorexia and weight loss.
|
Oncology (Williston Park)
11346935
|
6 |
3.963 |
2001 |
|
Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?
|
Ann Thorac Surg
11515864
|
11 |
3.7 |
2001 |
|
Folate status among patients with non-small cell lung cancer: a case-control study.
|
J Surg Oncol
11473373
|
5 |
2.993 |
2001 |
|
Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice.
|
Ann Nutr Metab
11423703
|
1 |
2.173 |
2001 |
|
On appetite and its loss.
|
J Clin Oncol
10920143
|
6 |
24.008 |
2000 |
|
Is ATP (adenosine 5'-triphosphate), like STP, a performance-enhancing additive for the tanks of cancer patients?
|
J Natl Cancer Inst
10675368
|
2 |
12.589 |
2000 |
|
Prognostic variables in male breast cancer.
|
Am Surg
10824754
|
3 |
0.7 |
2000 |
|
False-negative rates of tumor metastases in the histologic examination of bone marrow.
|
Mod Pathol
9950159
|
0 |
5.728 |
1999 |
|
Can pathology residents be trained to perform adequate bone marrow biopsies?
|
Acad Med
10219230
|
0 |
5.255 |
1999 |
|
The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer.
|
Lung Cancer
10217619
|
6 |
4.294 |
1999 |
|
Nutritional determinants of survival among patients with breast cancer.
|
Surg Clin North Am
10572555
|
2 |
2.206 |
1999 |
|
Bioavailability of phylloquinone from an intravenous lipid emulsion.
|
Am J Clin Nutr
9537619
|
1 |
6.926 |
1998 |
|
Parosteal osteosarcoma from a rib.
|
Ann Thorac Surg
9456137
|
1 |
3.7 |
1998 |
|
Protein-calorie malnutrition does not predict subtle vitamin K depletion in hospitalized patients.
|
Eur J Clin Nutr
9881890
|
1 |
3.057 |
1998 |
|
A cross-sectional study of vitamin intake in postoperative non-small cell lung cancer patients.
|
J Surg Oncol
9721708
|
0 |
2.993 |
1998 |
|
Using the absolute neutrophil count as a stand-alone test in a hematology/oncology clinic: an abbreviated test can be preferable.
|
Clin Lab Manage Rev
10185001
|
2 |
0 |
1998 |
|
A prospective survey for central line skin-site colonization by the pathogen Malassezia furfur among hospitalized adults receiving total parenteral nutrition.
|
JPEN J Parenter Enteral Nutr
9252950
|
0 |
4.22 |
1997 |
|
Surveying technologists: a novel method for establishing productivity standards in a clinical haematology laboratory.
|
Health Manpow Manage
10173520
|
0 |
0 |
1997 |
